AlphaCentric Advisors LLC - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 146 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.

Quarter-by-quarter ownership
AlphaCentric Advisors LLC ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$388,500
-19.7%
50,0000.0%0.22%
-18.2%
Q2 2023$484,000
-43.0%
50,000
-35.5%
0.27%
-54.1%
Q1 2023$849,400
-44.2%
77,500
-78.0%
0.59%
-61.1%
Q4 2022$1,522,800
+27.0%
352,500
+121.0%
1.50%
+22.4%
Q3 2022$1,199,000
+270.1%
159,500
+538.0%
1.23%
+1297.7%
Q2 2021$324,000
-28.6%
25,000
-28.6%
0.09%
-42.5%
Q1 2021$454,000
+63.9%
35,000
+75.0%
0.15%
+31.9%
Q4 2020$277,000
+361.7%
20,000
+387.8%
0.12%
+300.0%
Q3 2020$60,0004,1000.03%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders